04 Mar 2016

Further advances in cancer immunotherapy

Scancell Holdings Plc (SCLP:LON), 10.5 | Salvarx Group (SALV:LON), 0 | Oxford BioMedica plc (OXB:LON), 302

- Vadim Alexandre
- 6 pages

In the UK, a few quoted businesses operate in the area, including SalvaRx Ltd. (3Legs Resources plc*), Scancell Holdings plc, Redx Pharma plc and Oxford Biomedica plc, among others. All of these companies present an opportunity for investors to get exposure to the space.

Sign up to access

Get access to our full offering from over 30 providers

Get access to our full offering from over 30 providers

Further advances in cancer immunotherapy

Scancell Holdings Plc (SCLP:LON), 10.5 | Salvarx Group (SALV:LON), 0 | Oxford BioMedica plc (OXB:LON), 302

Published: 04 Mar 2016
Author: Vadim Alexandre
Pages: 6

In the UK, a few quoted businesses operate in the area, including SalvaRx Ltd. (3Legs Resources plc*), Scancell Holdings plc, Redx Pharma plc and Oxford Biomedica plc, among others. All of these companies present an opportunity for investors to get exposure to the space.

Top